For whom the "alarm" tolls: how we sense the danger of cigarette smoke and react to it.

[1]  A. Coyle,et al.  Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[2]  Alvar Agusti,et al.  Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.

[3]  C. Dinarello.  Interleukin-1beta and the autoinflammatory diseases. , 2009, The New England journal of medicine.

[4]  D. Kastner,et al.  Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. , 2009, The Journal of allergy and clinical immunology.

[5]  D. Postma,et al.  Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. , 2009, American journal of respiratory and critical care medicine.

[6]  P. Eriksson,et al.  A functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta:interleukin-1 receptor antagonist balance in atherosclerosis. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[7]  R. Stockley,et al.  Imbalances Between Interleukin-1 and Tumor Necrosis Factor Agonists and Antagonists in Stable COPD , 2009, Journal of Clinical Immunology.

[8]  U. Andersson,et al.  High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease , 2008, Arthritis research & therapy.

[9]  M. Bianchi.  DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.

[10]  Peter P. Nawroth,et al.  Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products1 , 2005, The Journal of Immunology.

[11]  K. Tracey,et al.  High Mobility Group Box Protein 1: An Endogenous Signal for Dendritic Cell Maturation and Th1 Polarization , 2004, The Journal of Immunology.

[12]  W. Arend.  The balance between IL-1 and IL-1Ra in disease. , 2002, Cytokine & growth factor reviews.

[13]  P. Matzinger.  The Danger Model: A Renewed Sense of Self , 2002, Science.

[14]  L. Fabbri,et al.  Cellular and structural bases of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.